GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED submitted its monthly return for equity securities as of 31 October 2025. The total authorised share capital remained at RMB1,625,790,949, composed of 219,900,000 H shares listed on the Hong Kong Stock Exchange and 1,405,890,949 A shares listed on the Shanghai Stock Exchange.

No changes were recorded in the issued share capital during October 2025. The number of issued H shares remained at 219,900,000, while the number of issued A shares remained at 1,405,890,949. Furthermore, there were no movements related to treasury shares, share options, warrants, or convertible securities.

All relevant confirmations under applicable listing rules have been provided. This monthly return was newly submitted on 04 November 2025 by the company's director, Cheng Ning.